India Vaccine Market Share, Growth, Size & Report | 2034
The India vaccine market was valued at INR 118.76 billion in 2024, driven by the high burden of infectious diseases, rising strategic collaborations, and increased focus on local vaccine production capabilities in the country. The market is expected to grow at a CAGR of 8.8% during the forecast period of 2025-2034, with the values likely to reach INR 278.53 billion by 2034. The vaccine market in India, covering its dynamics, trends, segmentation, and growth potential.
Get a Free Sample Report with a Table of Contents: https://www.expertmarketresearch.com/reports/indian-vaccine-market/requestsample
India Vaccine Market Overview
India is one of the largest producers and consumers of vaccines globally. The country’s vaccine market has grown significantly due to its large population, high disease burden, and robust pharmaceutical manufacturing infrastructure. Vaccines play a critical role in preventing the spread of infectious diseases and ensuring public health.
India’s vaccine market comprises a diverse range of vaccines, including paediatric, adult, travel, and combination vaccines. Additionally, the government’s strong support for immunisation programs, such as Mission Indradhanush, has enhanced vaccination coverage and driven demand for locally produced vaccines.
India Vaccine Market Dynamics
Drivers
-
High Burden of Infectious Diseases: India faces a significant prevalence of diseases such as tuberculosis, polio, and hepatitis, driving vaccine demand.
-
Government Initiatives: Immunisation programs like Mission Indradhanush and Universal Immunisation Programme (UIP) have boosted vaccine uptake.
-
Local Manufacturing Capabilities: India’s strong vaccine production capacity has positioned it as a global vaccine supplier.
-
Rising Public-Private Partnerships: Collaborations between the government and private sector have enhanced vaccine research and distribution.
-
Export Opportunities: India’s vaccine exports to countries in Africa, Asia, and Latin America contribute significantly to market growth.
Read Full Report with Table of Contents: https://www.expertmarketresearch.com/reports/indian-vaccine-market
Restraints
-
Vaccine Hesitancy: Misinformation and lack of awareness can hinder vaccination rates.
-
Supply Chain Challenges: Cold chain infrastructure limitations in rural areas affect vaccine distribution.
-
High Development Costs: The lengthy and expensive vaccine development process poses challenges for small players.
Opportunities
-
Focus on Adult Vaccination: Increasing awareness about vaccines for diseases like influenza and HPV offers growth potential.
-
Introduction of New Vaccines: Development of innovative vaccines for emerging diseases can drive market growth.
-
Digital Health Integration: Use of digital platforms for vaccine tracking and awareness campaigns enhances market reach.
External India Vaccine Market Trends
-
Rising Demand for Combination Vaccines: Vaccines offering protection against multiple diseases are gaining popularity.
-
Expansion of Travel Vaccines: Growing international travel is driving demand for vaccines like yellow fever and typhoid.
-
Focus on mRNA Technology: Following the success of COVID-19 vaccines, mRNA technology is being explored for other diseases.
-
Increased Investments in R&D: Government and private sector investments in vaccine research are driving innovation.
-
Sustainability Initiatives: Eco-friendly packaging and sustainable vaccine production methods are becoming a focus area.
India Vaccine Market Segmentation
By Vaccine Type:
-
Paediatric Vaccines:
-
Includes vaccines for measles, polio, rotavirus, and diphtheria.
-
-
Adult Vaccines:
-
Covers vaccines for influenza, HPV, and hepatitis.
-
-
Travel Vaccines:
-
Includes vaccines for yellow fever, typhoid, and meningitis.
-
-
Combination Vaccines:
-
Multi-valent vaccines that provide protection against multiple diseases in a single dose.
-
By Technology:
-
Inactivated Vaccines:
-
Includes vaccines with killed pathogens, such as the hepatitis A vaccine.
-
-
Live Attenuated Vaccines:
-
Vaccines like MMR and BCG, which use weakened pathogens.
-
-
Subunit and Toxoid Vaccines:
-
Includes diphtheria and pertussis vaccines.
-
-
mRNA Vaccines:
-
Emerging technology gaining traction post-COVID-19.
-
By End User:
-
Hospitals and Clinics:
-
The largest segment due to vaccine administration by healthcare professionals.
-
-
Government Distribution Programs:
-
Significant in rural and underserved areas.
-
-
Retail Pharmacies:
-
Growing as a convenient channel for adult and travel vaccinations.
-
India Vaccine Market Growth
The vaccine market in India is expected to experience robust growth, driven by rising healthcare awareness, increasing government spending, and advancements in vaccine technology. The growing demand for paediatric and adult vaccines, coupled with expanding export opportunities, will further fuel market expansion. Moreover, the introduction of new vaccines targeting emerging diseases and the integration of digital health tools are expected to drive future growth.
Recent Developments in the India Vaccine Market
-
GlaxoSmithKline Plc:
-
Expanded its vaccine portfolio in India with new launches for paediatric and adult immunisation.
-
-
Sanofi:
-
Collaborated with Indian manufacturers to enhance vaccine production capabilities.
-
-
Pfizer, Inc.:
-
Introduced advanced pneumococcal conjugate vaccines to cater to the rising demand in India.
-
India Vaccine Market Scope
The market scope includes a wide range of vaccines addressing various diseases and demographics. With increasing focus on public health, government support for immunisation programs, and technological advancements, the market scope continues to expand. Additionally, the rising emphasis on sustainability and equitable access is shaping the future of vaccine distribution and development in India.
India Vaccine Market Analysis
Regional Insights
-
North India:
-
The largest market share due to better healthcare infrastructure and high vaccination coverage.
-
-
South India:
-
Significant growth driven by advanced healthcare facilities and high awareness levels.
-
-
West India:
-
Growing adoption of vaccines in metropolitan cities like Mumbai and Pune.
-
-
East India:
-
Gradual growth expected with improving healthcare access and vaccination programs.
-
COVID-19 Impact Analysis
The COVID-19 pandemic significantly impacted the vaccine market in India, highlighting the importance of vaccination in public health. The rapid development and distribution of COVID-19 vaccines demonstrated India’s robust manufacturing capabilities. While the pandemic posed logistical challenges, it also increased public awareness about the importance of vaccines, leading to higher demand for both COVID-19 and non-COVID vaccines. Post-pandemic, the market is expected to sustain its growth momentum.
Key Players
-
GlaxoSmithKline Plc:
-
A global leader in vaccine development, focusing on paediatric and adult immunisation solutions.
-
-
Sanofi:
-
Known for its innovative vaccine portfolio and strong presence in the Indian market.
-
-
Pfizer, Inc.:
-
Renowned for its pneumococcal and mRNA vaccine offerings, addressing key health challenges in India.
-
FAQs
1. What drives the India vaccine market growth?
The market growth is driven by the high burden of infectious diseases, government initiatives, and advancements in vaccine technology.
2. Which vaccine types dominate the India market?
Paediatric and combination vaccines hold the largest share, followed by adult and travel vaccines.
3. How did COVID-19 impact the vaccine market in India?
The pandemic boosted vaccine awareness, accelerated technological advancements, and improved distribution infrastructure.
4. Which regions contribute most to the vaccine market in India?
North and South India dominate the market, with significant contributions from metropolitan cities.
5. Who are the key players in the India vaccine market?
GlaxoSmithKline Plc, Sanofi, and Pfizer, Inc. are prominent players driving innovation and growth in the market.
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian